11-deoxy-PGE1

11-deoxy-pge1 is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 188 references associated with 11-deoxy-PGE1 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 11-deoxy-PGE1

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 11-deoxy-PGE1

NCBI Entrez Crosslinks

All references with 11-deoxy-PGE1

Download all related citations
Per page 10 20 50 | Total 50
Authors Title Published Journal PubMed Link
Yamamoto E et al. Involvement of endogenous prostaglandin E2 in tubular epithelial regeneration through inhibition of apoptosis and epithelial-mesenchymal transition in cisplatin-induced rat renal lesions. 2010 Histol. Histopathol. pmid:20552550
Bidwell P et al. Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK. 2010 Prostaglandins Other Lipid Mediat. pmid:20015475
Leduc M et al. Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands. 2009 J. Pharmacol. Exp. Ther. pmid:19584306
Serkov IV and Bezuglov VV [O-Nitration of prostaglandins: synthesis of 15-O-nitrates of 11-deoxyprostaglandin E1 and its methyl ester]. 2006 Jan-Feb Bioorg. Khim. pmid:16523730
Hubich AI et al. Synthetic heteroprostanoids of A- and E-types as novel non-comprehensive inhibitors of adenylyl cyclase in rat hepatocytes. 2006 Biochem. Biophys. Res. Commun. pmid:16427025
Smukste I et al. Using small molecules to overcome drug resistance induced by a viral oncogene. 2006 Cancer Cell pmid:16473280
Tsujisawa T et al. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL. 2005 J. Bone Miner. Res. pmid:15619665
Sarrazin P et al. Role of EP3 and EP4 prostaglandin receptors in reorganization of the cytoskeleton in mature human osteoclasts. 2004 J. Rheumatol. pmid:15290741
Li RC et al. Prostacyclin induces apoptosis of vascular smooth muscle cells by a cAMP-mediated inhibition of extracellular signal-regulated kinase activity and can counteract the mitogenic activity of endothelin-1 or basic fibroblast growth factor. 2004 Circ. Res. pmid:14963006
Takahashi HK et al. Unique regulation profile of prostaglandin e1 on adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells. 2003 J. Pharmacol. Exp. Ther. pmid:14561849